Gerben Moolhuizen is the founder of Abalos Therapeutics. Abalos Therapeutics has raised $47M in total funding. Latest round: Series A.
Gerben Moolhuizen is the Chief Executive Officer of Abalos Therapeutics GmbH, a biotechnology company based in Düsseldorf, Germany focused on developing novel immuno-virotherapies against cancer. He has held the CEO role from October 2024 to the present. Abalos Therapeutics launched with a €12M Series A round and later completed a Series A extension bringing total raised funding to EUR 43 million.
Full founder directory · Investor directory · Company funding database · Fundraising library